Our Mission
To empower healthcare professionals to make a genuine difference in their patients’ lives
We provide clinicians with the best possible tools to guide decision-making by using advanced computer algorithms for structural MRI pattern recognition. Our goal is to help identify and assess neurodegenerative diseases at the earliest possible stage — so patients can live healthier, fuller lives for longer.
Our Innovation: Neuroreader®
The award-winning Neuroreader® is now a trusted assessment tool that:
- Automates brain volumetrics in under 10 minutes
- Quantifies 65+ brain structures with accuracy equal to or greater than manual segmentation
- Assists physicians in diagnosing and monitoring neurodegenerative diseases such as Alzheimer’s, TBI, and epilepsy
- Provides longitudinal tracking to support disease progression monitoring and treatment planning
The Neuroreader® Difference
Early diagnosis of neurodegenerative conditions is critical. With timely detection, physicians can:
- Design treatment plans that improve quality of life
- Slow disease progression
- Help patients and families prepare and adapt
By removing subjectivity and speeding up brain volumetric analysis, Neuroreader® enables clinicians to act earlier and with greater confidence.
Today & Beyond
Today, Brainreader is recognized as a global leader in brain volumetrics, trusted by clinicians and researchers worldwide. Our mission remains the same as it was in 2011: empower healthcare professionals with accurate, actionable insights that improve patient outcomes.
Our partners
Below you can see some of our partners.
